1.570CAD0.00%Mkt Cap: 221.02M CADP/E: —Last update: 2026-06-01
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vap…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap221.02M CAD
Enterprise Value254.98M CAD
Revenue (TTM)274.18M CAD
Gross Profit90.22M CAD
Net Income (TTM)-24.76M CAD
Revenue/Share2.036 CAD
Last Price1.570 CAD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees1.1K
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA68620P1018
Valuation
P/E (Trailing)—
P/E (Forward)52.33
PEG—
EV/EBITDA68.51
EV/Revenue0.93
P/S0.81
P/B0.56
EPS (TTM)-0.21
EPS (Forward)0.03
52W Range
1.4358% of range3.090
52W High3.090 CAD
52W Low1.435 CAD
Profitability
Gross Margin34.81%
Oper. Margin-16.38%
EBITDA Margin1.36%
Profit Margin-9.55%
ROE-7.09%
ROA-4.40%
Growth
Revenue Growth-8.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.59M CAD
CapEx (TTM)17.05M CAD
FCF Margin6.22%
FCF Yield7.71%
Net Debt-5.10M CAD
Net Debt/EBITDA-1.37
Balance Sheet
Debt/Equity0.03
Current Ratio2.82
Quick Ratio0.66
Book Value/Sh2.826 CAD
Cash/Share0.0390 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJul 7, 2023
Analyst Consensus
Rating—
Target (Mean)3.070 CAD
Target Range2.100 CAD – 4.000 CAD
# Analysts5
Ownership
Shares Out.140.78M
Float91.78M
Insiders30.26%
Institutions6.71%
Short Interest
Short Ratio9.1d
Short % Out.1.51%
Shares Short1.91M
Short (prev mo.)1.79M
Technical
SMA 501.826 (-14.0%)
SMA 2002.154 (-27.1%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)237.26K
Avg Vol (10d)228.57K
Technical Indicators
RSI (14)39.3
MACD-0.0923
MACD Signal-0.0985
MACD Hist.+0.0062
BB Upper2.008 CAD
BB Middle1.659 CAD
BB Lower1.311 CAD
BB Width42.06%
ATR (14)0.0797 CAD
Vol Ratio (20d)0.79x